Publications:

Short-term dynamics of circulating tumor DNA predicting efficacy of sintilimab plus docetaxel in second-line treatment of advanced NSCLC: biomarker analysis from a single-arm, phase 2 trial.

Journal For Immunotherapy Of Cancer

Han, Xiao X; Tang, Xiaoyong X; Zhu, Hui H; Zhu, Dongyuan D; Zhang, Xiqin X; Meng, Xiangjiao X; Hua, Ying Y; Wang, Zhongtang Z; Zhang, Yan Y; Huang, Wei W; Wang, Linlin L; Yuan, Shuanghu S; Zhang, Pinliang P; Gong, Heyi H; Sun, Yulan Y; Zhang, Yingjie Y; Liu, Zengjun Z; Dong, Xiaomeng X; Gai, Fei F; Huang, Zhan Z; Zhu, Changbin C; Guo, Jun J; Wang, Zhehai Z

Publication Date: 2022-12

Variant appearance in text: DOT1L: 376A>C; N126H

PubMed Link: 36600554

Variant Present in the following documents:

• jitc-2022-004952supp005.pdf

View BVdb publication page